"FDA approves Dymicron’s study of cervical artificial disc" was originally created and published by Medical Device Network, a GlobalData owned brand.

The IDE approval enables Dymicron to initiate a multi-center, prospective, historically controlled clinical trial comparing the safety and effectiveness of Triadyme-C to anterior cervical ...

About the Triadyme–C The Triadyme-C is a next-generation, motion-preserving cervical artificial disc made of Adymite (polycrystalline diamond), one of the most wear-resistant materials known to man.

Dymicron’s Triadyme-C artificial disc earned the FDA’s investigational device exemption approval, according to a July 10 news release. The IDE approval opens the door for a U.S. trial of the ...

Dymicron is a privately held, innovative medical device company based in Orem, Utah. The Company has developed a ...

Joseph Osorio, MD, PhD, performed the first cervical spine surgery using Carlsmed’s aprevo device, the company said July 28. The aprevo devices are designed with Carlsmed’s proprietary artificial ...

This could be a generational age of innovation, and this may be the best way to ensure your portfolio captures the opportunity.

Today, however, the opportunities to find quality artificial intelligence (AI) stocks hanging on the discount rack may seem fewer and farther between. But that's not to say that they don't exist.

In current times, it seems that everything is under the control of Artificial Intelligence. That is why OneFootball didn't want to miss the opportunity to ask the now-famous AI for its ideal XI of ...